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DESCENDING/THORACOABDOMINAL IIStrategies for renal and visceral protection in thoracoabdominal
aortic surgeryJoseph S. Coselli, MDThe complexity of thoracoabdominal aortic aneurysm
(TAAA) repair has long been established. In the earliest
days of aortic repair, various techniques were tried in the
hope of minimizing ischemic damage to downstream organs.
These techniques included decreasing the duration of aortic
and visceral artery clamping times with an approach that fo-
cused on restoring the renal arteries first, and working back-
ward to complete the aortic repair, using passive shunts to
maintain an oxygenated blood supply, and inducing hypo-
thermia to reduce metabolic demand.1,2 Nonetheless, in
the modern era, renal and visceral ischemia remain life-
threatening complications of TAAA repair.3COLD CRYSTALLOID RENAL PERFUSION
At our clinic, our approach has been to provide cold crys-
talloid renal perfusion whenever possible, and to selectively
perfuse the celiac axis and superior mesenteric arteries as
part of our multimodal approach to TAAA repair, which is
guided by the Crawford extent of repair as described else-
where.4 This approach includes moderate systemic heparin-
ization, permissive mild hypothermia (32C–34C), and
multiple adjuncts for avoiding spinal cord ischemic injury.
Cold crystalloid (lactated Ringer solution) renal perfusion
during TAAA repair has been used since the 1970s.5-7 Its
use does not depend on the concurrent use of left heart
bypass (LHB), which is typically limited to more extensive
extent I and II TAAA repairs and may be delivered through
a separate perfusion circuit in all extents of TAAA repair.
Thus in our day-to-day practice, renal perfusion is generally
usedwhenever surgical exposureof the renal ostia is sufficient.
After the origins of the renal arteries are exposed, 9F bal-
loon perfusion catheters are inserted and used to deliver cold
(4C) crystalloid fluid from a cardiotomy reservoir with 1/4 -
inch tubing threaded through a roller-head pump. An initial
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The Journal of Thoracic and Cardinstilled in the renal arteries, followed by intermittent infu-
sions of 200 to 300 mL every several minutes until arterial
flow has been reestablished.
Our large clinical practice has provided us with unique
opportunities to conduct randomized clinical trials regarding
renal perfusion. In one such trial, we compared 2 commonly
used renal perfusates: cold crystalloid fluid and isothermic
blood. Our analysis showed that patients who received inter-
mittent cold crystalloid perfusion had a significantly lower
incidence of postoperative renal dysfunction than did pa-
tients who received continuous isothermic blood perfusion.
On multivariable analysis, cold crystalloid perfusion was
found to be independently protective against acute renal
dysfunction.8
Recently, we attempted to determine whether cold blood
could offer even better renal protection than cold crystalloid
fluid. Patients were randomly assigned to receive either cold
blood from the LHB circuit or cold crystalloid fluid from
a separate circuit. Satisfactory levels of renal hypothermia
were achieved in all cases, and the degree of hypothermia
achieved did not affect renal outcome. In each group, only
a few patients (3% each) had renal failure that necessitated
hemodialysis, and there were no differences in urinary bio-
markers of subclinical renal injury. In addition, the incidence
of early death did not differ significantly between the cold
blood (8%) and cold crystalloid (6%) groups (P ¼ .8).9
Although this randomized trial did not support our hy-
pothesis that cold blood would provide better renal protec-
tion than cold crystalloid fluid, it did confirm that using
cold renal perfusion during TAAA repair provides effective
protection against renal injury. We remain proponents of
cold crystalloid renal perfusion, which is easier to use and
can routinely be applied to greater numbers of patients
with TAAA than perfusion with hypothermic or normother-
mic blood.
At present, it is not clear how commonly cold renal perfu-
sion is used during TAAA repair. Several centers have
reported that cold crystalloid fluid, cold saline solution,
cold blood, and other cold electrolyte solutions provide
effective renal protection.8-12 Recent guidelines endorse
the consideration of cold crystalloid or cold blood renal
perfusion (class IIb, level of evidence B) but do not
address other substrates.13 Further study may identify addi-
tional substrates for cold renal protection during TAAA
repair. The need for protective renal perfusion will probably
remain high, because many patients with TAAA have preex-
isting renal dysfunction, which has clearly been associated
with early death and morbidity.iovascular Surgery c Volume 140, Number 6S S147
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Although LHB is the primary means of providing distal
aortic perfusion during TAAA repair, it is used sparingly
and is generally limited to Crawford extents I and II.14
Also, LHB is used early in the repair, during the proximal
anastomosis, and is usually discontinued for the visceral ar-
tery reconstruction portion of the repair. To extend the ben-
efits of providing oxygenated blood to the viscera while
distal anastomoses are being performed, the LHB circuit
may be rerouted by incorporating 9F balloon perfusion cath-
eters into a Y-line from the arterial perfusion line of the LHB
circuit. These catheters are then placed, under direct vision,
into the ostia of the celiac axis and superior mesenteric
arteries, where they provide continuous, controlled flow at
low volumes. The balloon catheters may provide additional
protection by preventing atherosclerotic debris from enter-
ing the cannulated arteries or by minimizing active bleeding
from these arteries.15
Although there is scant evidence to support the use of di-
rect visceral perfusion,13 shunts have long been used in
TAAA repair, and some clinicians still enthusiastically sup-
port their use.16 Balloon perfusion catheters may have
advantages relative to passive shunts, because the flow rate
of blood is better controlled. A potential disadvantage of
using balloon catheters is the possibility of perforating or
rupturing the vessel during use; however, we have found
this risk to be low. Because using these perfusion catheters
adds little time to the overall repair and may help prevent
such dreaded complications as mesenteric ischemia, postop-
erative coagulopathy, and bacterial translocation, we con-
tinue to use this technique selectively in extents of repair
in which the origins of the visceral arteries are exposed.ADDITIONAL TECHNIQUES TO ENHANCE
VISCERAL PERFUSION
Not uncommonly, visceral arteries are replaced with by-
pass grafts, or other methods are used to improve their
blood-carrying capacity, such as endarterectomy or the use
of balloon expandable stents.17 Before Crawford’s reassess-
ment of the renal first approach,18,19 visceral arteries were
routinely reattached as individual graft branches, rather
than as part of the visceral patch that is commonly used
today. Currently, small-diameter Dacron polyester fabric
grafts (and, rarely, reversed saphenous veins) are used as
needed to replace visceral arteries, particularly the left renal
artery because it tends to be somewhat separated from the
other visceral branches.
Likewise, endarterectomy has been used since the 1950s
to remove atherosclerotic material near vessel ostia, but end-
arterectomy also removes a portion of the aortic wall, thin-
ning it. Working under Crawford, we found that renal
endarterectomy significantly improved renal outcomes in
patients with preoperative renal dysfunction.7S148 The Journal of Thoracic and Cardiovascular SurVisceral stents are a relatively newaddition to the surgeon’s
armamentarium17,20 and are helpful in treating occlusive
disease, obliterating the false lumen in cases of dissection,
and preventing kinking in graft branches. Visceral stents
may also secure intimal end points after endarterectomy,
maintain patent ostia near the patch anastomosis, and
facilitate the safe use of perfusion catheters.
Although the previously mentioned techniques are gener-
ally considered safe and effective, their potential drawbacks
include a friable endarterectomized vessel wall that is diffi-
cult to manipulate safely, the additional operative time re-
quired to complete individual branch anastomoses,
possible perforation of the vessel by the stent, stent migra-
tion, and the risk of thrombosis in a branch vessel.17,20,21
Currently, we use visceral perfusion–enhancing techniques
in more than half of our patients with TAAA to treat
branch vessel stenosis. Placement of small-diameter bypass
grafts is the most commonly used approach.
CONCLUSIONS
In summary, the aortic surgeon must continue to explore
and refine surgical techniques to prevent operative compli-
cations, including potentially lethal complications that
stem from renal or visceral ischemia during TAAA repair.
We remain enthusiastic proponents of cold crystalloid renal
perfusion, which is easier to use and can routinely be applied
to greater numbers of patients undergoing TAAA repair than
perfusion with either hypothermic or normothermic blood.
Also, further study may identify better renal or visceral per-
fusion strategies, as well as any patient-specific therapeutic
limits of such strategies, and enable continued reductions
in mortality and morbidity to ensure optimal outcomes for
individual patients with TAAA.
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